Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
The evolution of cancer treatment has seen a significant shift towards targeted therapies, which offer more precise and effective outcomes with fewer side effects. Central to the development of these advanced treatments are specialized chemical intermediates, such as N-methyl-2-sulfanylbenzamide (CAS: 20054-45-9). This compound is indispensable in the synthesis of Axitinib, a potent tyrosine kinase inhibitor, marking it as a critical component in the fight against various cancers. NINGBO INNO PHARMCHEM CO.,LTD., a leading chemical manufacturer and supplier from China, plays a vital role in providing this essential material to the global pharmaceutical sector.
N-methyl-2-sulfanylbenzamide is recognized for its role as a key pharmaceutical intermediate in the production of Axitinib. The drug's mechanism of action targets specific signaling pathways that drive cancer cell growth and survival. Therefore, the quality and purity of N-methyl-2-sulfanylbenzamide are paramount to ensure the successful synthesis of an effective and safe therapeutic agent. Pharmaceutical companies rely on trusted sources for this axitinib synthesis intermediate to maintain the integrity of their drug manufacturing processes. As a dedicated pharmaceutical intermediate manufacturer, NINGBO INNO PHARMCHEM CO.,LTD. ensures stringent quality control measures are implemented throughout the production process.
The journey of N-methyl-2-sulfanylbenzamide from a chemical compound to a building block for a life-saving drug highlights the importance of a robust and reliable supply chain. By providing high-grade N-methyl-2-sulfanylbenzamide, we enable researchers and manufacturers to advance their drug development programs without compromise. Our commitment to being a leading supplier in China means not only delivering quality products but also ensuring timely delivery and competitive pricing for our N-methyl-2-sulfanylbenzamide. This focus on the price for N-methyl-2-sulfanylbenzamide aims to support the economic viability of pharmaceutical R&D and production.
The field of targeted cancer therapy continues to expand, with chemical innovation driving the discovery of new treatments. N-methyl-2-sulfanylbenzamide, as a crucial tyrosine kinase inhibitor precursor, is at the heart of this progress. We are proud to supply this vital pharmaceutical raw material 20054-45-9, contributing to the development of next-generation cancer therapies and ultimately improving patient outcomes worldwide. Choosing NINGBO INNO PHARMCHEM CO.,LTD. as your partner ensures access to high-quality chemical intermediates essential for the advancement of medical science.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
